Nitrofural or nitrofurazone

This classification denotes an antispasmotic agent with the molecular formula C6H6N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X8XI70B5Z6, chemically known as 2-furancarboxaldehyde, 5-nitro-, semicarbazone but generally known as nitrofural, which bears US NIH Compound Identifier 1839. European Medicines Agency schedules Nitrofural in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09325MIG. The term NITROFURAL is an International Non-Proprietary Name. World Health Organization schedules nitrofural in its Anatomical Therapeutic Chemical (ATC) Classification. NITROFURAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, NITROFURAZONE remains the US FDA Preferred Term for this commodity. Nitrofurazone bears US NLM NCI C73150. SMILES: O1C(CCC1[N](=O)O)/C=N/NC(=O)N.